Advanced Oncotherapy (AONCF) 0.1450 $AONCF
Top 100 Global 'Best in Stock Markets' Medical Devices/Technology/Supplies Compamnies 2015
M2 - Wed Apr 15, 8:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wxtwtv/global_best_in) has announced the addition of the "Global Best in Stock Markets Medical Devices/Technology/Supplies 100" report to their offering. This newly launched report identifies 100 Best in Stock Markets medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. Medical devices sector constitutes a fast growing global market with innovative devices providing breakthroughs in earlier and better diagnoses and medical treatments that bring clinical benefits to patients at a cost savings to the healthcare system and the individual patients. The medical device industry might not be the perfect industry for a long-term investor - there are some issues on the horizon and new frictional costs that keep it from being sublime. But no industry is perfect, and if there was one, the market would just overbuy it and it'd become too expensive anyway. Medical devices are pretty close to perfect, despite the ongoing intellectual property wars between competitors, and a new medical device tax courtesy of the Affordable Healthcare Act. 2014 has turned out to be a pretty decent year for the world's 40 largest medical device companies. Only six of them have seen their stock prices decline, and the gainers on an average have seen stock prices increase about 27%. Some are doing even better, either because of unexpected sales growth or because they are acquisition targets. Report Highlights: - Global Best in Stock Markets 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and Stock market performances - Important M&A and alliances of Global Best in Stock Markets medical devices/technology/supplies companies with foreign companies - International presence of Global Best in Stock Markets medical devices/technology/supplies companies - Key R&D activities by Global Best in Stock Markets medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 3: Key News of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies with foreign companies 5: Research and Development Activities by Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 6: International Presence of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies Sample list of company names included in this industry report: - A&T Corporation (Japan) - Abaxis Inc. (United States) - Abiomed, Inc. (United States) - Advanced Oncotherapy PLC (United Kingdom) - Affymetrix, Inc. (United States) - Andon Health Company Limited (China) - Asahi Intecc Co., Ltd. (Japan) - Atcor Medical Holdings Ltd (Australia) - Atect Corp (Japan) - Beijing Bohui Innovation Tech (China) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosino Bio-Technology & Science Incorporation (Hong Kong) - Blue Sail Medical Co Ltd (China) - Boule Diagnostics AB (Sweden) - Capitol Health Ltd (Australia) - Careplus Group Berhad (Malaysia) - Cellavision AB (Sweden) - Changsha Kaiyuan Instruments Co Ltd (China) - Compumedics Limited (Australia) - Cormedix (United States) - CVSL Inc (United States) - DongGuan Eontec Co, Ltd (China) - El.En SpA (Italy) - Guangdong Shirongzhaoye Co. Ltd. (China) - Lifeloc Technologies Inc. (United States) - Mani Incorporated (Japan) - Milestone Scientific Inc. (United States) - Netcare Limited (South Africa) - Tristel PLC (United Kingdom) - WaferGen Bio-systems, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/wx...al_best_in
CVSL: 1.18 (+0.06), WGBS: 2.76 (-0.01), MLSS: 3.40 (+0.11), AFFX: 11.05 (+0.26), ABAX: 53.47 (+2.97)
100 M&A Focused Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7d4bk7/manda_focused) has announced the addition of the "M&A Focused Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This report newly launched report identifies 100 M&A Focused medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Alliances and partnerships have traditionally been used to help companies reduce their funding and resource burden and provide potential upside. These non-dilutive sources of funding can take many forms and warrant a second look in the light of today's difficult economy. A panel of seasoned medical device executives will analyze several recent partnering deals and contemplate their usefulness as alternative funding sources. Practical take-away include: how to integrate product co-development into your innovation strategy, understanding the key differences in structuring partnership deals with large and small companies and universities and/or research centers, understanding the pitfalls, risks and opportunities that these partnering models present, and understanding how to leverage these relationships to create win-win scenarios to the benefit all participants. M&A environment in 2015 is anticipated to continue its strong growth trends. Strategic and private equity acquisition appetites for strong healthcare companies continue to grow and this offers tremendous liquidity opportunities for business owners. As strategic acquirers become increasingly aggressive in their pursuit of new sources of growth, the robust capital markets welcome the next wave of growth companies. Despite significant challenges in reimbursement and other operating factors, many healthcare providers continue to grow profitably by scaling their businesses. While this growth comes at a significant cost to gross margins, we see efficient companies continuing to generate strong overall profits and hence, attractive acquisition opportunities. Report Highlights: - M&A Focused 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of M&A Focused medical devices/technology/supplies companies with foreign companies - International presence of M&A Focused medical devices/technology/supplies companies - Key R&D activities by M&A Focused medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of M&A Focused Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 M&A Focused Medical Devices/Technology/Supplies Companies 3: Key News of M&A Focused Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of M&A Focused Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by M&A Focused Medical Devices/Technology/Supplies Companies 6: International Presence of M&A Focused Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of M&A Focused Medical Devices/Technology/Supplies Companies Companies Mentioned Sample list of company names included in this industry report: - 3M Company (United States) - Abaxis Inc (United States) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alfresa Pharma Corp (Japan) - Andon Health Company Limited (China) - Angiodynamics, Inc. (United States) - Anteo Diagnostics Limited (Australia) - Atcor Medical Holdings Ltd (Australia) - Azure Healthcare Ltd. (Australia) - Bio Rad Laboratories Incorporated (United States) - Bruker Corporation (United States) - Capitol Health Ltd (Australia) - Carefusion Corporation (United States) - Carl Zeiss Co., Ltd. (Japan) - Cellectis SA (France) - Coherent Incorporated (United States) - Cooper Companies Inc. (United States) - Corgenix Medical Corporation (United States) - Dynasil Corporation Of America (United States) - Heartware International Inc (Australia) - Hill-Rom Holdings, Incorporation (United States) - Jeol Limited (Japan) - Paragon Care Limited (Australia) - Smith & Nephew PLC (United Kingdom) - Tecan Group AG (Switzerland) - Veracyte, Inc. (United States) - Vitrolife AB (Sweden) - Volcano Corporation (United States) For more information visit http://www.researchandmarkets.com/research/7d...da_focused
MMM: 154.95 (+1.20), COO: 176.12 (+1.44), SNN: 34.89 (+0.83), VCYT: 10.77 (+1.22), ABAX: 53.47 (+2.97), DYSL: 1.58 (+0.12), VOLC: 17.99 (+0.01), CLLS: 35.72 (+1.27), COHR: 62.48 (+1.13), HRC: 54.12 (+0.74)
100 R&D Intensive Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gjbtw4/randd_intensive) has announced the addition of the "R&D Intensive Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 R&D Intensive medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Over the past few years the way the medical devices industry assesses innovation and new technology has changed. The old dynamic of the physician as judge of value has been replaced with the government, private insurers, and consumers increasingly determining what sells and at what price point. Consumers refuse to pay for incremental enhancements that add bells and whistles that do not improve health or reduce cost. The faster, better, smaller, cheaper innovations in medical devices are the devices that will maintain a sustainable advantage. Recently, global market has been taking the lead in developing lean, frugal, and reverse innovation. This type of innovation simplifies devices and processes, retaining essential functions, while applying new technologies that are more versatile, mobile, and adaptable to consumer's needs and are less expensive. The global companies in medical devices/technology industry are highly R&D intensive and technology based. Such companies, on an average, spend 12% of their revenues on R&D each year in order to develop, design, and commercialize innovative medical devices. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the R&D Intensive companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - R&D Intensive 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of R&D Intensive medical devices/technology/supplies companies with foreign companies - International presence of R&D Intensive medical devices/technology/supplies companies - Key R&D activities by R&D Intensive medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of R&D Intensive Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 R&D Intensive Medical Devices/Technology/Supplies Companies 3: Key News of R&D Intensive Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of R&D Intensive Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by R&D Intensive Medical Devices/Technology/Supplies Companies 6: International Presence of R&D Intensive Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of R&D Intensive Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - 3 D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/gj..._intensive
ATEC: 1.40 (+0.03), GBSNU: 17.44 (+0.04), MZOR: 14.33 (+0.20), FEIC: 81.58 (+0.67), ZLTQ: 28.07 (+0.59), IART: 63.06 (+0.98), BVX: 2.40 (+0.14)
Week In Review: Zai Lab To Develop BMS' Liver Cancer Drug In China
ChinaBio Today - at Seeking Alpha - Sun Mar 29, 3:08AM CDT
Deals and Financings ZAI Lab of Shanghai in-licensed China rights to a liver cancer drug candidate from Bristol-Myers Squibb (NYSE: BMY ). Brivanib is an oral kinase inhibitor that is in Phase III trials for oncology indications including...
CCM: 6.39 (+0.06), WX: 40.50 (+0.96), CASI: 1.70 (+0.05), BMY: 69.27 (+1.38)
Top 100 Global 'Best in Stock Markets' Medical Devices/Technology/Supplies Compamnies 2015
M2 - Wed Apr 15, 8:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wxtwtv/global_best_in) has announced the addition of the "Global Best in Stock Markets Medical Devices/Technology/Supplies 100" report to their offering. This newly launched report identifies 100 Best in Stock Markets medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. Medical devices sector constitutes a fast growing global market with innovative devices providing breakthroughs in earlier and better diagnoses and medical treatments that bring clinical benefits to patients at a cost savings to the healthcare system and the individual patients. The medical device industry might not be the perfect industry for a long-term investor - there are some issues on the horizon and new frictional costs that keep it from being sublime. But no industry is perfect, and if there was one, the market would just overbuy it and it'd become too expensive anyway. Medical devices are pretty close to perfect, despite the ongoing intellectual property wars between competitors, and a new medical device tax courtesy of the Affordable Healthcare Act. 2014 has turned out to be a pretty decent year for the world's 40 largest medical device companies. Only six of them have seen their stock prices decline, and the gainers on an average have seen stock prices increase about 27%. Some are doing even better, either because of unexpected sales growth or because they are acquisition targets. Report Highlights: - Global Best in Stock Markets 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and Stock market performances - Important M&A and alliances of Global Best in Stock Markets medical devices/technology/supplies companies with foreign companies - International presence of Global Best in Stock Markets medical devices/technology/supplies companies - Key R&D activities by Global Best in Stock Markets medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 3: Key News of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies with foreign companies 5: Research and Development Activities by Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 6: International Presence of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Best in Stock Markets Medical Devices/Technology/Supplies Companies Sample list of company names included in this industry report: - A&T Corporation (Japan) - Abaxis Inc. (United States) - Abiomed, Inc. (United States) - Advanced Oncotherapy PLC (United Kingdom) - Affymetrix, Inc. (United States) - Andon Health Company Limited (China) - Asahi Intecc Co., Ltd. (Japan) - Atcor Medical Holdings Ltd (Australia) - Atect Corp (Japan) - Beijing Bohui Innovation Tech (China) - Beijing Wandong Medical Equipment Co. Ltd. (China) - Biosino Bio-Technology & Science Incorporation (Hong Kong) - Blue Sail Medical Co Ltd (China) - Boule Diagnostics AB (Sweden) - Capitol Health Ltd (Australia) - Careplus Group Berhad (Malaysia) - Cellavision AB (Sweden) - Changsha Kaiyuan Instruments Co Ltd (China) - Compumedics Limited (Australia) - Cormedix (United States) - CVSL Inc (United States) - DongGuan Eontec Co, Ltd (China) - El.En SpA (Italy) - Guangdong Shirongzhaoye Co. Ltd. (China) - Lifeloc Technologies Inc. (United States) - Mani Incorporated (Japan) - Milestone Scientific Inc. (United States) - Netcare Limited (South Africa) - Tristel PLC (United Kingdom) - WaferGen Bio-systems, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/wx...al_best_in
CVSL: 1.18 (+0.06), WGBS: 2.76 (-0.01), MLSS: 3.40 (+0.11), AFFX: 11.05 (+0.26), ABAX: 53.47 (+2.97)
100 M&A Focused Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7d4bk7/manda_focused) has announced the addition of the "M&A Focused Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This report newly launched report identifies 100 M&A Focused medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Alliances and partnerships have traditionally been used to help companies reduce their funding and resource burden and provide potential upside. These non-dilutive sources of funding can take many forms and warrant a second look in the light of today's difficult economy. A panel of seasoned medical device executives will analyze several recent partnering deals and contemplate their usefulness as alternative funding sources. Practical take-away include: how to integrate product co-development into your innovation strategy, understanding the key differences in structuring partnership deals with large and small companies and universities and/or research centers, understanding the pitfalls, risks and opportunities that these partnering models present, and understanding how to leverage these relationships to create win-win scenarios to the benefit all participants. M&A environment in 2015 is anticipated to continue its strong growth trends. Strategic and private equity acquisition appetites for strong healthcare companies continue to grow and this offers tremendous liquidity opportunities for business owners. As strategic acquirers become increasingly aggressive in their pursuit of new sources of growth, the robust capital markets welcome the next wave of growth companies. Despite significant challenges in reimbursement and other operating factors, many healthcare providers continue to grow profitably by scaling their businesses. While this growth comes at a significant cost to gross margins, we see efficient companies continuing to generate strong overall profits and hence, attractive acquisition opportunities. Report Highlights: - M&A Focused 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of M&A Focused medical devices/technology/supplies companies with foreign companies - International presence of M&A Focused medical devices/technology/supplies companies - Key R&D activities by M&A Focused medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of M&A Focused Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 M&A Focused Medical Devices/Technology/Supplies Companies 3: Key News of M&A Focused Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of M&A Focused Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by M&A Focused Medical Devices/Technology/Supplies Companies 6: International Presence of M&A Focused Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of M&A Focused Medical Devices/Technology/Supplies Companies Companies Mentioned Sample list of company names included in this industry report: - 3M Company (United States) - Abaxis Inc (United States) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alfresa Pharma Corp (Japan) - Andon Health Company Limited (China) - Angiodynamics, Inc. (United States) - Anteo Diagnostics Limited (Australia) - Atcor Medical Holdings Ltd (Australia) - Azure Healthcare Ltd. (Australia) - Bio Rad Laboratories Incorporated (United States) - Bruker Corporation (United States) - Capitol Health Ltd (Australia) - Carefusion Corporation (United States) - Carl Zeiss Co., Ltd. (Japan) - Cellectis SA (France) - Coherent Incorporated (United States) - Cooper Companies Inc. (United States) - Corgenix Medical Corporation (United States) - Dynasil Corporation Of America (United States) - Heartware International Inc (Australia) - Hill-Rom Holdings, Incorporation (United States) - Jeol Limited (Japan) - Paragon Care Limited (Australia) - Smith & Nephew PLC (United Kingdom) - Tecan Group AG (Switzerland) - Veracyte, Inc. (United States) - Vitrolife AB (Sweden) - Volcano Corporation (United States) For more information visit http://www.researchandmarkets.com/research/7d...da_focused
MMM: 154.95 (+1.20), COO: 176.12 (+1.44), SNN: 34.89 (+0.83), VCYT: 10.77 (+1.22), ABAX: 53.47 (+2.97), DYSL: 1.58 (+0.12), VOLC: 17.99 (+0.01), CLLS: 35.72 (+1.27), COHR: 62.48 (+1.13), HRC: 54.12 (+0.74)
100 R&D Intensive Medical Devices/Technology/Supplies Companies 2015
M2 - Wed Apr 15, 8:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gjbtw4/randd_intensive) has announced the addition of the "R&D Intensive Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 R&D Intensive medical devices/technology/supplies companies and covers various aspects of these 100 companies including news, financial/non-financial information, and stock market analysis. Over the past few years the way the medical devices industry assesses innovation and new technology has changed. The old dynamic of the physician as judge of value has been replaced with the government, private insurers, and consumers increasingly determining what sells and at what price point. Consumers refuse to pay for incremental enhancements that add bells and whistles that do not improve health or reduce cost. The faster, better, smaller, cheaper innovations in medical devices are the devices that will maintain a sustainable advantage. Recently, global market has been taking the lead in developing lean, frugal, and reverse innovation. This type of innovation simplifies devices and processes, retaining essential functions, while applying new technologies that are more versatile, mobile, and adaptable to consumer's needs and are less expensive. The global companies in medical devices/technology industry are highly R&D intensive and technology based. Such companies, on an average, spend 12% of their revenues on R&D each year in order to develop, design, and commercialize innovative medical devices. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends of the R&D Intensive companies in the medical industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - R&D Intensive 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of R&D Intensive medical devices/technology/supplies companies with foreign companies - International presence of R&D Intensive medical devices/technology/supplies companies - Key R&D activities by R&D Intensive medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of R&D Intensive Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 5 Years: Leading 25 R&D Intensive Medical Devices/Technology/Supplies Companies 3: Key News of R&D Intensive Medical Devices/Technology/Supplies Companies for Year 2014 4: Important Alliances of R&D Intensive Medical Devices/Technology/Supplies Companies with Foreign Companies 5: Research and Development Activities by R&D Intensive Medical Devices/Technology/Supplies Companies 6: International Presence of R&D Intensive Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of R&D Intensive Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - 3 D Matrix Ltd. (Japan) - aap Implantate AG (Germany) - Abcam Plc (United Kingdom) - Advanced Oncotherapy PLC (United Kingdom) - Aerocrine Ab (Sweden) - Alphatec Holdings, Inc. (United States) - Analytica Limited (Australia) - Angiodynamics, Inc. (United States) - Animalcare Group Plc (United Kingdom) - Ansell Limited (Australia) - Astrazenca Plc (United Kingdom) - Avacta Group Plc (United Kingdom) - Avita Medical Limited (Australia) - Avita Medical Europe Limited (United Kingdom) - Axogen Inc. (United States) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bluechiip Limited (Australia) - Bovie Medical Corporation (United States) - Brain Resource Ltd (Australia) - Exiqon A/S (Denmark) - FEI Company (United States) - Great Basin Scientific Inc. (United States) - Integra LifeSciences Holdings Corporation (United States) - Lifewatch AG (Switzerland) - Mazor Robotics Limited (Israel) - Sekisui Medical Co., Ltd. (Japan) - Simavita Ltd. (Australia) - Sorin SpA (Italy) - Zeltiq Aesthetics Inc. (United States) For more information visit http://www.researchandmarkets.com/research/gj..._intensive
ATEC: 1.40 (+0.03), GBSNU: 17.44 (+0.04), MZOR: 14.33 (+0.20), FEIC: 81.58 (+0.67), ZLTQ: 28.07 (+0.59), IART: 63.06 (+0.98), BVX: 2.40 (+0.14)
Week In Review: Zai Lab To Develop BMS' Liver Cancer Drug In China
ChinaBio Today - at Seeking Alpha - Sun Mar 29, 3:08AM CDT
Deals and Financings ZAI Lab of Shanghai in-licensed China rights to a liver cancer drug candidate from Bristol-Myers Squibb (NYSE: BMY ). Brivanib is an oral kinase inhibitor that is in Phase III trials for oncology indications including...
CCM: 6.39 (+0.06), WX: 40.50 (+0.96), CASI: 1.70 (+0.05), BMY: 69.27 (+1.38)
